HomeAI · summaries
Storia in 3 fonti
PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models
Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
ADA: Amgen highlights Repatha perks, GLP-1 pitfalls in push to boost cardiometabolic pedigree
As Amgen strives to become the industry’s top player in cardiometabolic risk reduction by the start of the next decade, the company took to the American Diabetes Association 2026…
- ·
fiercehealthcare.com
PCMA unveils new policy platform aimed at drug affordability
The Pharmaceutical Care Management Association released a new policy platform, which includes six | The Pharmaceutical Care Management Association released a new policy platform,…
